Skip to content

Clinical trials

Active, not recruiting Phase 2 Pulmonary Disease, Chronic Obstructive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 2 Status: Active, not recruiting Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20221
20231
20243
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Areteia Therapeutics1
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1
Haisco Pharmaceutical Group Co., Ltd.1
Merck Sharp & Dohme LLC1
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.1
Uniquity One (UNI)1
University of Alberta1
University of Virginia1
Upstream Bio Inc.1
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive10
Emphysema2
Bronchitis, Chronic1
Dyspnea1
Hypertension, Pulmonary1
Pneumonia1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.